LJI Wealth Management LLC Invests $1.89 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

LJI Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 20,385 shares of the exchange traded fund’s stock, valued at approximately $1,890,000.

A number of other hedge funds and other institutional investors have also modified their holdings of XBI. ICA Group Wealth Management LLC bought a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $27,000. Scarborough Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $32,000. BOCHK Asset Management Ltd acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $36,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter worth $40,000. Finally, Vima LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $45,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $100.81 on Thursday. The company has a market cap of $7.68 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a 50-day moving average of $98.78 and a 200-day moving average of $93.87. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.